ArticleBMJ open diabetes research & care2024

Serum isthmin-1 is a potential biomarker for metabolic dysfunction associated fatty liver disease in patients with metabolic syndrome and type 2 diabetes mellitus.

Xiaohui Lei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.